Guildford, UK, 11 June 2015: ReNeuron Group plc (AIM: RENE), a leading UK-based stem cell therapy company, is pleased to announce two further senior management appointments. The appointments are part of a phased restructuring and broadening of the Company’s executive and non-executive management as ReNeuron moves into its next phase of development.